5PSQ-144 Development and validation of clinical rules to address risk prescriptions

Autor:	C Sving, T Gustavsson, E Johansson, U Gillespie
Rok vydání:	2022
Zdroj:	Section 5: Patient safety and quality assurance.
DOI:	10.1136/ejhpharm-2022-eahp.342
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e485b4660efcbb3f4cef508e8bd112ea https://doi.org/10.1136/ejhpharm-2022-eahp.342 Zobrazit plný text záznamu